Annual Current Liabilities
$95.85 M
+$8.90 M+10.23%
November 30, 2024
Summary
- As of February 8, 2025, NRIX annual total current liabilities is $95.85 million, with the most recent change of +$8.90 million (+10.23%) on November 30, 2024.
- During the last 3 years, NRIX annual current liabilities has risen by +$29.60 million (+44.67%).
- NRIX annual current liabilities is now at all-time high.
Performance
NRIX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$95.85 M
+$9.56 M+11.08%
November 30, 2024
Summary
- As of February 8, 2025, NRIX quarterly total current liabilities is $95.85 million, with the most recent change of +$9.56 million (+11.08%) on November 30, 2024.
- Over the past year, NRIX quarterly current liabilities has increased by +$8.23 million (+9.39%).
- NRIX quarterly current liabilities is now at all-time high.
Performance
NRIX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NRIX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.2% | +9.4% |
| 3 y3 years | +44.7% | +47.7% |
| 5 y5 years | +494.0% | +47.7% |
NRIX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.7% | at high | +55.9% |
| 5 y | 5-year | at high | +494.0% | at high | +494.0% |
| alltime | all time | at high | +494.0% | at high | +494.0% |
Nurix Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | $95.85 M(+10.2%) | $95.85 M(+11.1%) |
| Aug 2024 | - | $86.30 M(+6.8%) |
| May 2024 | - | $80.78 M(-7.8%) |
| Feb 2024 | - | $87.62 M(+0.8%) |
| Nov 2023 | $86.96 M(+23.1%) | $86.96 M(+41.4%) |
| Aug 2023 | - | $61.49 M(-14.9%) |
| May 2023 | - | $72.26 M(+11.4%) |
| Feb 2023 | - | $64.88 M(-8.2%) |
| Nov 2022 | $70.66 M | $70.66 M(+4.7%) |
| Aug 2022 | - | $67.50 M(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| May 2022 | - | $72.67 M(+10.0%) |
| Feb 2022 | - | $66.05 M(-0.3%) |
| Nov 2021 | $66.26 M(+48.8%) | $66.26 M(+30.7%) |
| Aug 2021 | - | $50.68 M(+8.2%) |
| May 2021 | - | $46.84 M(-2.4%) |
| Feb 2021 | - | $47.97 M(+7.7%) |
| Nov 2020 | $44.54 M(+176.0%) | $44.54 M(+8.6%) |
| Aug 2020 | - | $41.01 M(+19.1%) |
| May 2020 | - | $34.44 M(+113.4%) |
| Nov 2019 | $16.14 M(-50.8%) | $16.14 M |
| Nov 2018 | $32.83 M | - |
FAQ
- What is Nurix Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Nurix Therapeutics?
- What is Nurix Therapeutics annual current liabilities year-on-year change?
- What is Nurix Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly current liabilities year-on-year change?
What is Nurix Therapeutics annual total current liabilities?
The current annual current liabilities of NRIX is $95.85 M
What is the all time high annual current liabilities for Nurix Therapeutics?
Nurix Therapeutics all-time high annual total current liabilities is $95.85 M
What is Nurix Therapeutics annual current liabilities year-on-year change?
Over the past year, NRIX annual total current liabilities has changed by +$8.90 M (+10.23%)
What is Nurix Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of NRIX is $95.85 M
What is the all time high quarterly current liabilities for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly total current liabilities is $95.85 M
What is Nurix Therapeutics quarterly current liabilities year-on-year change?
Over the past year, NRIX quarterly total current liabilities has changed by +$8.23 M (+9.39%)